Amiloride Hydrochloride

CHEMBL1398126 Phase 4 Đã phê duyệt Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
302.1 g/mol
LogP
Phase
4

The hydrochloride salt form of amiloride, an epithelial sodium channel blocker that promotes urine production while preserving potassium levels in the body. This formulation is used in combination diuretic regimens for hypertension and edema management.

Khối lượng phân tử

302,1200 g/mol

TPSA

161,00 Ų

Lĩnh vực điều trị

Cơ chế tác dụng

Inhibits sodium reabsorption in the renal tubules, promoting excretion of sodium, chloride, and water. This reduces extracellular fluid volume and cardiac preload, lowering blood pressure.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Cơ chế

Inhibits sodium reabsorption in the renal tubules, promoting excretion of sodium, chloride, and water. This reduces extracellular fluid volume and cardiac preload, lowering blood pressure.

Cấu trúc 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

Cl.N=C(N)NC(=O)c1nc(Cl)c(N)nc1N.O.O

InChI

InChI=1S/C6H8ClN7O.ClH.2H2O/c7-2-4(9)13-3(8)1(12-2)5(15)14-6(10)11;;;/h(H4,8,9,13)(H4,10,11,14,15);1H;2*1H2

Molecular Formula

C6H13Cl2N7O3

HBD / HBA

7 / 7

Liên kết có thể quay

1

Nguyên tử nặng

18

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Câu hỏi thường gặp

The hydrochloride salt form of amiloride, an epithelial sodium channel blocker that promotes urine production while preserving potassium levels in the body. This formulation is used in combination diuretic regimens for hypertension and edema management.

Inhibits sodium reabsorption in the renal tubules, promoting excretion of sodium, chloride, and water. This reduces extracellular fluid volume and cardiac preload, lowering blood pressure.

Yes, Amiloride Hydrochloride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1398126. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 68540. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Tuyên bố miễn trách y tế

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.